Skip to main content
Sign In

University of Colorado Department of Biochemistry and Molecular Genetics

Biochemistry and Molecular Genetics

Robert A. Sclafani, PhD


Ph.D., Columbia University, 1981

Contact Information:

Phone: (303) 724-3271​

Graduate Program Memberships

H​uman Medical Genetics​
Cancer Biology​
Molecular Biology​


The main area of focus of the laboratory is the regulation and mechanisms of chromosomal DNA replication, mutagenesis and DNA repair in yeast and human cells. Elucidation of these mechanisms is important for determining the etiology of a number of diseases, especially cancer, in which the regulation is altered. Yeast (Saccharomyces cerevisiae), as a eukaryotic microorganism is an excellent model system because facile molecular and high-throughput genomic techniques can be used in combination with classical biochemical and genetic methods. We also use molecular genetic high-throughput genomic analysis of cultured human cancer cells for our studies that are focused on exploiting the deregulation of the cell cycle that occurs in cancer cells as a target for chemoprevention and therapy.

Yeast: Our current studies focus on the regulation of the initiation of DNA replication in yeast. DDK (Dbf4-dependent kinase; also known as Cdc7/Dbf4) is a protein kinase that regulates the initiation of DNA replication during the somatic cell cycle (for reviews, see Sclafani and Holzen, 2007; Rossbach and Sclafani, in press). DDK phosphorylates the MCM complex, a multi-subunit DNA helicase found at origins of DNA replication, to initiate the S phase. Both DDK and CDK (cyclin-dependent kinase) protein kinases are needed for multiple steps that ultimately intersect to activate the MCM helicase and to load on DNA polymerases during initiation (Zhong et al., 2013). Our structure-function studies of the MCM complex use the Archaeal MCM helicase as a structural model and yeast MCM as a functional, physiological model for replication (Fletcher et al., 2003; Leon et al., 2008; Ramey and Sclafani, 2014). DDK also acts to regulate error-prone translesion synthesis by DNA polymerase , which is important for mutagenesis (Pessoa-Brandão and Sclafani, 2004; Brandão et al., 2014). Rad53/Chk2 protein kinase interacts with DDK function in initiation that is separate from its replication checkpoint function and involves changes in orgin chromatin structure (Dohrmann and Sclafani, 2006; Holzen and Sclafani, 2010).

Humans: We are determining the mode of action of several compounds found in natural products that function in cancer chemoprevention (Grape Seed extract, silibinin, IP6, resveratrol). These compounds are known to prevent cancer in animal models and are not toxic to normal cells. We have shown that the cell cycle is frequently the target of these compounds resulting in G1 cell cycle arrest (Roy et al., 2007; 2009; Kaur et al., 2011). In contrast, the compound resveratrol that is found in red grape skins and wine activates the DNA damage checkpoint pathway by producing replication stress resulting in S phase arrest and cell death in cancer cells (Tyagi et al., 2005 & 2011; Shrotriya et al., 2015). These studies are in collaboration with Dr. Rajesh Agarwal of the University of Colorado School of Pharmacy.

​Current Lab Colleagues

 Results From Research : Selected site and subsites
PicturesLast NameFirst NameJob TitleEmailBio Page
DutchikJamesProfessional Research  


Former Sclafani Lab Members 1985-2009:

PhD students:
Robert E. Hollingsworth, Ph.D. 1985-1990 Director of Oncology at Medimmune, LLC, MD
Jin-Yuan (Jimmy) Su, Ph.D.1986-1991 Professor at National Ming University, Taiwan
Aimee (Brown) Jackson, Ph.D.1989-1994 Senior Scientist at Miragen, Inc., Boulder, CO.
Paula Pahl, Ph.D.1988-1995 President, Denver Pen Women, CO
Peter Hovland, M.D., Ph.D.1989-1995-Colorado Retina Associates, Denver, CO
Yiqun (Gui) Shellman, Ph.D. 1993-1998-Associate Professor, Dermatology, University of Colorado
Guy Oshiro, Ph.D. 1994-1999 Scientific Application Developer, John McNeil & Co., Inc., CA
Bryn Grimison, Ph.D. 1996-2001 Research Scientist-Insmed, Inc., Boulder, CO
Luis Pessoa (Brandão), Ph.D. 2000-2006-Scientist at Gevo in Englewood, CO
Lora Wilson, Ph.D. 2000-2006- Oncology Field Medical Director, Pfizer Pharmaceuticals.
Ronald Leon, Ph.D. 2001-2007 Senior Research Associate, University of Oregon, Portland, OR

Postdoctoral Fellows:
Margaret van Boldrick, Ph.D. 1986-1987 Madison, WI
Rachel Ostroff, Ph.D.1989-1993 Clinical Research Director-SomaLogic, Inc. Boulder, CO
Irene Schauer, M.D., Ph.D. 1992-1996 Assistant Professor, Medicine, University of Colorado
Anne Galbraith, Ph.D. 1995-1998 Associate Professor, University of Wisconsin
Marguerite (Dalton) Kosovsky, Ph.D. 1996-1998, Northborough MA
Maria (Daly) Todd, Ph.D.1997-2000 Associate Professor, Southwestern University, Texas
Taroh Satoh, M.D.2001-2003 Medical Oncologist, Kinki University, Japan
Paul Dohrmann, Ph.D.1994-2000 Research Associate, University of Colorado
Angela Pierce, Ph.D. 1998-2000 Research Associate, University of Colorado
Rebecca Ferguson 2011-2014 Research Associate, University of Colorado

M.S. students:
Lee A. Niswander, Ph.D. M.S.-1985 -Professor, Pediatrics, University of Colorado

Professional Research Assistants:
Bruce Thalley, M.A. 1985-1987
Michael Klein, M.S., MBA 1987-1993; Deceased.
Marianne Tecklenburg, 1994-2009; Retired